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Abstract:  Lobophora variegata, a brown alga collected from the coast of the Yucatan 
peninsula, Mexico, was studied for antiprotozoal activity against Giardia intestinalis, 
Entamoeba histolytica and Trichomonas vaginalis. The whole extract showed the highest 
activity against T. vaginalis, with an IC50 value of 3.2 μg/mL. For the fractions, the best 
antiprotozoal activity was found in non-polar fractions. The chloroform fraction of the 
extract contained a major sulfoquinovosyldiacylglycerol (SQDG), identified as   
1-O-palmitoyl-2-O-myristoyl-3-O-(6´´´-sulfo-α-D-quinovopyranosyl)-glycerol (1), together 
with small amounts of 1,2-di-O-palmitoyl-3-O-(6´´´-sulfo-α-D-quinovopyranosyl)-glycerol (2) 
and a new compound identified as 1-O-palmitoyl-2-O-oleoyl-3-O-(6´´´-sulfo-α-D-
quinovopyranosyl)-glycerol (3). Their structures were elucidated on the basis of chemical 
and enzymatic hydrolysis and careful analysis of FAB-MS and NMR spectroscopic data. 
This is the first report on the isolation of SQDGs from L. variegata. The mixture of 1–3 
showed good activity against E. histolytica and moderate activity against T. vaginalis with 
IC50s of 3.9 and 8.0 μg/mL, respectively, however, the activity of 1–3 is not as effective as 
metronidazole. These results afford ground information for the potential use of the whole 
extract and fractions of this species in protozoal infections. 
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1. Introduction 
The three anaerobic protozoa, Entamoeba histolytica, Giardia intestinalis (commonly referred to as 
Giardia lamblia) and Trichomonas vaginalis are highly prevalent human-infective parasites with a 
worldwide distribution, which despite their significant differences in life-cycle and pathogenic 
properties are customarily grouped together based on their carbohydrate metabolism and their lack of 
mitochondria [1]. Enteric protozoan infections produced by G. lamblia and E. histolytica are a 
significant cause of morbidity and mortality in developing countries. Symptomatic patients typically 
present diarrhea and abdominal symptoms, including stomachache, cramps, bloating or tenderness. 
Entamoeba histolytica is estimated to cause severe disease in 48 million people, killing 70,000 each 
year [2]. Although G. intestinalis rarely causes a lethal disease, it is the most common intestinal 
parasite of humans in developed countries. In Asia, Africa and Latin America, about 200 million 
people have symptomatic giardiasis, with about 500,000 new cases reported each year [3]. On the 
other hand, Trichomoniasis is a common sexual transmitted disease caused by T. vaginalis which 
infects the urogenital tract of men and women. Worldwide, it is responsible for the annual infection of 
180 million people [4]. This has been associated with vaginitis, cervicitis, urethritis, prostatitis, 
epididymitis, cervical cancer, infertility and pelvic inflammatory disease [5]. Currently, the drug of 
choice for treating these infections is metronidazole, a 5-nitroimidazole derivative that possesses 
activity against anaerobic microorganisms [6]. However, resistance to metronidazole has been 
demonstrated in these protozoans, both in natural and experimental conditions [7]. Also, 
metronidazole is effective with prolonged treatment or high doses and can produce many side effects 
including headache, nausea, gastrointestinal disturbance, anorexia and dizziness [8]. Recent studies 
have also demonstrated cytotoxic effects of metronidazole [9]. Therefore, the search for more efficient 
and safer antiprotozoal agents is justified. 
Throughout history the plant kingdom has provided a variety of medicines. It is noticeable that 
most of the studies have focused on natural substances derived from higher plants, mainly due to their 
accessibility. Nevertheless, the metabolic and physiological capabilities of marine organisms that 
allow them to survive in complex habitat provide a great potential for production of secondary 
metabolites, which are not found in terrestrial environments. Thus, marine algae are among the richest 
sources of known and novel bioactive compounds [10,11]. In the course of our ongoing investigations 
toward the isolation of bioactive metabolites from marine algae of the Yucatan coast (Mexico), we 
recently studied the bioactivity of several algal species belonging to the three algae divisions: 
Phaeophyta, Chlorophyta and Rhodophyta (brown, green and red algae respectively). The results 
showed that the brown alga Lobophora variegata has high antiparasitic activity [12,13] as well as 
antioxidant activity [14]. Therefore, L. variegata was selected for fractionation and isolation of its 
antiprotozoal constituents. In this paper we report the antiprotozoal activity of the whole extract and 
fractions from L. variegata, using in vitro antiprotozoal assay, as well as the isolation of three Mar. Drugs 2010, 8                           
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sulfoquinovosyl-diacylglycerols 1–3 (SQDGs 1–3) from the chloroform fraction of the total extract 
with antiprotozoal activity. The cytotoxicity of the whole extract, fractions and SQDGs 1–3 on 
mammalian cells was also assessed in order to provide selective index for further studies. 
2. Results and Discussion 
The dried and powered alga Lobophora variegata was extracted with 7:3 dichloromethane-methanol 
and concentrated at 45 °C. The resulting dried extract was dissolved in methanol-water (9:1) and 
successively partitioned against hexane, chloroform, ethyl acetate and n-butanol, following a modified 
Kupchan procedure [15]. The chloroform fraction showing the best antiprotozoal activity against the 
three protozoa G. intestinalis, E. histolytica and T. vaginalis (see Table 3) was chosen for further 
fractionation and isolation of its components. Chromatographic fractionation on Sephadex LH-20, 
allowed the isolation of a mixture of SQDGs 1–3 (Figure 1). The mixture of SQDGs was colorless 
amorphous powder, apparently homogenous on TLC, yielding purplish pink spots on spraying with 
methanolic sulfuric acid. 
Figure 1. Structures of SQDG´s 1–3 isolated from Lobophora variegata. 
1   R1= palmitoyl   R2= myristoyl
2   R1= palmitoyl   R2= palmitoyl
3   R1= palmitoyl   R2= oleoyl
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Careful analysis of the 
1H- and 
13C-NMR data including 
1H-
1H COSY, TOCSY, DEPT, HSQC and 
HMQC spectra, allowed the assignment of all 
13C- and 
1H-NMR signals (Table 1). Three spin systems 
were recognized, the first one was assigned to a glycerol moiety [δH 4.34 and 4.13 (δC 62.7); δH 5.13 
(δC 69.8); δH 3.89 and 3.39 (δC 64.6)]. 
The cross-peaks in the HMBC spectrum [δH /δC: 5.13 (Hsn-2)/172.4, 172.6 (COO); 4.34 and 4.13 
(Hsn-1)/172.4, 172.6 (COO); 2.28 (α-CH2)/ 172.4, 172.6 (COO)] indicated the presence of acyl groups 
on the sn-1 and sn-2 positions of the glycerol moiety. Therefore, the second spin system signals were 
attributable to two fatty acyl groups whose terminal methyl signals appeared overlapped at δH 0.84 
(6H, t, J = 6.9 Hz, δC 14.0). 
The third spin system indicated the presence of a glycosyl moiety. Combination of TOCSY and 
COSY data allowed the identification of a sequence of four oxymethynes and one deshielded 
methylene. Hence, taking the anomeric proton at δH 4.57 (δC 98.3) as a safe entry, this proton showed 
cross-peaks with signals at δH 2.92, 3.18 and 3.35 in the TOCSY spectrum. 
Similarly, the methylene protons at δH 2.90 and 2.54 showed cross-peaks with the same signals, 
besides the signal at δH 3.77, indicating that all these signals belongs to an hexapyranose with the 
substitution pattern and relative stereochemistry similar to glucose. Then, COSY spectrum allowed 
unambiguous assignment of all protons of the glycosyl moiety (see Table 1). Mar. Drugs 2010, 8                           
 
 
1295
Table 1. NMR spectroscopic data for mixture of 1–3. 
 Compounds  1 and 2 Compound  3 
position  δH/mult., (J in Hz)  δC  δH /mult., (J in Hz) δ C 
1a  4.34 dd (12.0, 2.4)  62.7  4.34 dd (12.0, 2.4)  62.7 
1b  4.13 dd (12.0, 7.5)    4.13 dd (12.0, 7.5)   
2  5.13 m  69.8  5.13 m  69.8 
3a  3.89 dd (10.5, 6.0)  64.6  3.89 dd (10.5, 6.0)  64.6 
3b 3.39    3.39     
1´´´  4.57 d (3.5)  98.3  4.57 d (3.5)  98.3 
2´´´  3.18 dd (3.5, 9.6)  71.7  3.18 dd (3.5, 9.6)  71.7 
3´´´ 3.35  72.9  3.35  72.9 
4´´´  2.92 dd (9.6)   74.2  2.92 dd (9.6)   74.2 
5´´´ 3.77  ddd (9.6, 6.8, 4.3)  68.6  3.77 ddd (9.6, 6.8, 4.3)  68.6 
6´´´a  2.90 dd (14.0, 4.3)  54.5  2.90 dd (14.0, 4.3)  54.5 
6´´´b  2.54 dd (14.0, 6.9)    2.54 dd (14.0, 6.9)   
1´, 1´´    172.4, 172.6    172.4, 172.6 
2´, 2´´  2.28 m  33.6  2.28 m  33.6 
3´, 3´´  1.49 m  31.4  1.49 m  31.4 
8´´, 11´´      1.97 m  26.7 
9´´, 10´´      5.3 t (4.7)  129.61, 129.64 
-CH2  1.22 bs  29.2–22.2  1.22 bs  29.2–22.2 
CH3  0.84 t (6.9)  14.0  0.84 t (6.9)  14.0 
Recorded in DMSO-d6 at 400 MHz; chemical shifts, multiplicity and coupling constants (J, Hz) 
were assigned by means of 
1H-, 
13C-NMR and 2D NMR data. 
Confirmation of the linkage of the glycosyl moiety at sn-3 of glycerol, was based on the HMBC 
cross-peak between the anomeric proton (H-1´´´, δH 4.57) and carbon C-3 at δC 64.6. The relative 
small coupling constant value of the anomeric proton (H-1´´´), J = 3.5 Hz, indicated the α orientation 
of the glycosidic union, while the large vicinal coupling constants observed between H-2´´´/H-3´´´,  
H-3´´´/H-4´´´ and H-4´´´/H-5´´´ (J = 9.6 Hz), indicated the glucopyranosyl nature of the sugar moiety. 
On the other hand, the 
1H- and 
13C-NMR characteristic chemical shifts of the methylene protons,  
H-6´´´ (δH 2.90 and 2.54) and carbon C-6´´´(δC 54.5) indicated the presence of a sulphonyl group 
attach at C-6´´´ carbon, of the sugar, instead of the hydroxyl group of glucose [16]. The presence of a 
small triplet at δH 5.31 (J = 4.7 Hz) due to olefinic protons in the 
1H-NMR, spectrum suggested the 
presence of small amounts of another compound with an unsaturated fatty acid (Table 1). 
All proton and carbon NMR data are in good agreement with the presence of 6-deoxy-6-sulpho-α-
D-glucopyranosyl-1,2-O-diacyl-glycerols. To identify the acyl substituents at sn-1 and sn-2 in the 
mixture, enzymatic and alkaline hydrolysis were performed. It is known that the enzymatic hydrolysis 
using Lipase from Mucor javanicus, regioselectively liberate the acyl moiety at sn-1 position [17]. The 
GC-MS analysis of the enzymatic hydrolysis product indicated the presence of palmitic acid only. 
Thus, it was concluded that the palmitoyl residue was attached to sn-1 position of the glycerol moiety 
in the mixture. 
On the other hand, to infer the exact nature of the fatty acids in sn-2 position, the mixture was 
subjected to alkaline hydrolysis with NaOMe in MeOH. After partitioning, the organic extract was Mar. Drugs 2010, 8                           
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analyzed by GC/MS, the composition of the fatty acid methyl esters was shown to be methyl 
myristate, methyl oleate and methyl palmitate, being the last in greater proportion. 
In this study, the mass spectra of the mixture of SQDGs were obtained by FAB in negative and 
positive ion modes. Careful analysis of the spectra allowed the identification of three compounds. The 
diagnostic ion peaks [M-H + 2Na]
+ (at m/z 811, 839 and 865) appearing in the positive-ion FAB 
spectrum and [M-H]
− (at m/z 766, 794 and 820) in the negative-ion FAB spectrum. Confirmation of 
the double sodium adduct was determined by HR-FAB-MS, where the peak at m/z 811 is in 
accordance with the formula of C39H73O12SNa2 (m/z 811.4614, C39H73O12SNa2, requires 811.4618). 
The presence of [M-H+2Na]
+ instead of [M+Na]
+ in the positive-ion FAB spectrum is due to the 
acidity of the sulfonic acid group at position 6 of the sugar unit [18]. Namely, the positive charge is 
located at the terminal sulfonic group. This is further supported by the presence of a prominent peak at 
m/z 126 in the positive-ion FAB spectrum, which can be assigned to the [SO3Na2]
+ ion. The 
nomenclature for cleavages of SQDG proposed by Costello and co-workers is adopted in this   
paper [19,20]. Thus, we can divide the fragmentation ions into two types, one generated by the 
cleavage of the sugar moiety and the other by the cleavage of the fatty acyl chains (Figure 2). All the 
ions observed in the positive-ion FAB spectrum correspond to sodium-attached ions. The cleavage of 
the interglycosidic bond results in the ion peak at m/z 271. Two ions resulting from the concurrent 
cleavage of the bond β or γ to the carbonyl group of one fatty acyl chain and the cleavage of the ester 
bond of the other fatty acyl chain are observed at m/z 387 (
2D1,2) and 401 (
3D1,2), respectively. The 
other ions observed are mainly produced by the fragmentation of fatty acyl groups. The loss of the acyl 
groups as the corresponding fatty acid (-RCOOH) can be observed as the ions G1 and G2. For SQDG´s 
1–3 three ions G1 resulting from the loss of palmitic acid at sn-1 position are observed at m/z 555, 583 
and 609 respectively. One only ion G2 is observed for the three compounds and is produced by the loss 
of myristic, palmitic and oleic acids respectively at position sn-2. Other ions that supported the 
presence of three SQDGs can be observed in Figure 2 and Table 2. 
Figure 2. Nomenclature for cleavage of glycolipids and some fragmentation scheme of 
SQDG [18]. For the cleavage of fatty acyl chains the subscript in the symbol represents the 
relative position (sn-1 or sn-2) of the cleavage in the fatty acyl chain and the superscript 
the cleaved bond position relative to the carbonyl carbon of the fatty acyl group. In the 
proposed positive ions there are two sodium ions attached at the terminal sulfonic group. 
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Table 2. Fragmentation assignment of product ions observed in positive mode FAB-MS of 
sodium adducted molecular ions of the mixture of SQDGs 1–3. 
  Product ions, m/z 
Assignment 
SQDG-1 
[M-H+2Na]
+ = 811 
SQDG-2 
[M-H+2Na]
+ = 839 
SQDG-3 
[M-H+2Na]
+ = 865 
B 271  271  271 
E 329  329  329 
2D1,2 387 387 387 
3D1,2 401 401 401 
G1 555  583  609 
G2 583  583  583 
H1 571  599  625 
H2 599  599  599 
3I1 627  655  681 
3I2 655  655  655 
SO3Na2
+ 126  126  126 
On the basis of the molecular formula obtained by high resolution positive FAB MS, 
1H- and  
13C-NMR data and the results from the selective hydrolysis, the structure of compound 1 was established 
as 1-O-palmitoyl-2-O-myristoyl-3-O-(6´´´-sulfo-α-D-quinovopyranosyl)-glycerol, while compounds 2 
and  3 were identified as 1,2-di-O-palmitoyl-3-O-(6´´´-sulfo-α-D-quinovopyranosyl)-glycerol and   
1-O-palmitoyl-2-O-oleoyl-3-O-(6´´´-sulfo-α-D-quinovopyranosyl)-glycerol, respectively. 
Concerning the stereochemistry at C-2 in the glycerol portion, it was tentatively assumed to be S, 
based on comparison of the NMR data and optical rotation of 1–3 ([α]
25
D + 43.18 in MeOH, c 0.44) 
with those of the SQDGs isolated from Byrsonima crassifolia [21]. Furthermore, most of natural 
glycoglycerolipids, including SQDGs of known absolute stereochemistry have S-configuration   
(sn-1,2-diacylglycerols) [22]. As for the quinovose (6-deoxyglucose) moiety, it was assumed to have 
the D-configuration, based on the common configuration of glucose in nature [23]. 
Shao  et al. [24], reported the isolation of the sulfoglycolipid crassicaulisine, with myristoyl   
and palmitoyl as acyl groups at positions 1 and 2 of glycerol respectively, from the red alga   
Chondria crassicaulis. Compound 1, the major SQDG of L. variegata, corresponds to the positional 
isomer of crassicaulisine, where palmitoyl and miristoyl acyl groups are interchanged, i.e., at sn-1 and 
sn-2 respectively. There is a solitary reference in the literature on the identification of 1 from the 
brown alga Ishige okamurai [25]. In the case of compound 2, it has been isolated from several 
terrestrial and marine sources, as from leaves of Byrsonima crassifolia [21,26], from the   
brown seaweeds Ishige okamurai and Sargassum parvivesiculosum [25,27], from the green algae 
Caulerpa racemosa and Dictyochloris fragrans with notable selective antiviral activity against HSV-2 
and a P-selectin receptor inhibitor [16,28]. Concerning compound 3, there are no reports of its 
isolation from natural sources; therefore it corresponds to a new natural product. Recently, the 
isolation of the glucosyldiacylglycerol 4, from the brown alga Sargassum fulvellum, was published 
(Figure 3). The proposed structure differing from 3 only in the presence of a glucosyl moiety, instead 
of the sulfonic derivative at C-6´´´ [29]. However, it is noteworthy the chemical shift reported for  Mar. Drugs 2010, 8                           
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C-6´´´ of the  glucose at δC 54.9, which is characteristic value for C-6’’’ in sulfoglycolypids or 
aminoglycolipids. Therefore, the structure 4 should be revised. 
Figure 3. Glucosyldiacylglycerol isolated from Sargassum fulvellum. 
4   R1= palmitoyl   R2= oleoyl
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Previous studies have reported extensive biological effects for SQDG, such as DNA polymerase 
inhibition, immunosuppressive effect, human immunodeficiency virus reverse transcriptase inhibition, 
antimicrobial and anti-tumor activities [30–35]. In this study, the evaluation of the whole extract 
(dichloromethane-methanol) and its partition fractions (hexane, chloroform, ethyl acetate, n-butanol 
and aqueous residue) against G. intestinalis, E. histolytica and T. vaginalis, was carried out. Due to the 
lack of data on antiprotozoal activity scores from natural product extracts, we define high activity as 
an IC50 ≤ 5 μg/mL, moderate activity as IC50 5.1–10 μg/mL and low activity as IC50 > 10 μg/mL [12]. 
The cytotoxic effect on one normal cell line (MCDK) was determined using the MTT assay. In order 
to evaluate the level of harmfulness of the substances on normal cells, the selectivity index (SI) of each 
extract and fractions was also determined, it is generally considered that biological efficacy is not due 
to cytotoxicity when SI ≥ 10 [36]. 
The antiprotozoal activity (IC50) of the whole extract and its fractions are shown in Table 3. The 
whole extract of Lobophora showed high activity against T. vaginalis with IC50 value of 3.2 μg/mL and 
low activity against G. intestinalis and E. histolytica (IC50 10.5 and 10.8 μg/mL respectively). When the 
whole extract was fractionated by polarity, fractions showed variable activity against the protozoa. 
In case of Giardia intestinalis, the chloroform fraction was the most active (0.5 μg/mL), but also 
the activity of hexane and ethyl acetate fractions were very good (1.0 and 0.8 μg/mL, respectively). 
The activity of chloroform fraction is close to that of metronidazole (drug used as the positive control) 
and the selectivity index is adequate (SI = 175). Only the n-butanol fraction was not active. 
In case of Entamoeba histolytica, the ethyl acetate fraction was the most active with an IC50 of  
1.7 μg/mL (SI = 294.2). The activity of hexane fraction, however, was also important, with an IC50 of 
2.8 μg/mL. T. vaginalis trophozoites were sensible to whole extract and chloroform fraction (3.2 and 
3.7 μg/mL, respectively), while the n-butanol fraction and aqueous residue were inactive. 
For fractions, the best antiprotozoal activity was found in non-polar fractions. From these, the 
chloroform fraction showed the best activity against the three protozoa with good selectivity (SI > 10), 
therefore, it was chosen for the isolation of active compounds. 
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Table 3. Antiprotozoal activity, cytotoxic activity on Madin-Darby canine kidney cells and 
selectivity index of whole extract, fractions and compounds from Lobophora variegata. 
Extract/fraction/
compound 
(weight) 
Antiprotozoal activity 
IC50 μg/mL 
 
Cytotoxicity 
CC50 μg/mL 
  Selectivity index 
SI 
Gi Eh Tv    MDCK    MDCK/Gi  MDCK/Eh  MDCK/Tv 
Whole extract 
(35.5 g)  10.5 ± 0.45  10.8± 0.09  3.2± 0.09    78.0 ± 2.45    7.4  7.2  24.4 
Hexane fraction 
(10 g)  1.0 ± 0.06  2.8 ± 0.08  13.4 ± 0.61    65.0 ± 1,23    65  23.2  4.9 
Chloroform 
fraction (3.6 g)  0.5 ± 0.02  6.2 ± 0.32  3.7 ± 0.11    87.5 ± 0.89    175  14.1  23.6 
Ethyl acetate 
fraction (16.7 g)  0.8 ± 0.03  1.7 ± 0.04  11.7 ± 0.22    500.1 ± 3.4    625.1  294.2  42.7 
n-butanol 
fraction (3.4 g)  -  15.5 ± 0.73  -    90.8 ± 1.78    nt  5.9  nt 
Aqueous 
residue (1.8 g)  8.8 ± 0.71  15.6 ± 0.41  -    789.9 ± 2.67   89.8  50.6  nt 
SQDG´s 1–3 
(276.3 mg)  20.9 ± 0.89  3.9 ± 0.03  8.0 ± 0.42    85.3 ± 1.26    4.1  21.9  10.7 
Metronidazole  0.22 ± 
0.0005 
0.13 ± 
0.0005  0.04 ± 0.02    68 ± 1.2    309  523  1700 
Gi: Giardia intestinalis; Eh: Entamoeba histolytica; Tv: Trichomonas vaginalis; - inactive >50 μg/mL; nt: not tested. 
The mixture of SQDGs 1–3  isolated from the chloroform fraction  was tested  for antiprotozoal 
activity. The mixture showed high in vitro activity against E. histolytica (IC50 3.9 μg/mL) and 
moderate activity against T. vaginalis trophozoites (IC50 8 μg/mL) with good selective index (SI > 10) 
(Table 3) however, the activity of 1–3 is not as effective as metronidazole. In addition, the chloroform 
fraction showed the stronger activity than the purified compounds against G. intestinalis and  
T. vaginalis. This could be attributed that the SQDGs are not the major inhibitory compounds on the 
parasites growth and that the inhibitory effects are attributed to other unidentified compounds in the 
same fraction and/or occurrence of synergistic activities between different components within a 
fraction. These results show the possibility that crude extract and non-polar fractions from L. variegata 
could be used rather than the purified SQDGs for development of new antiprotozoal drugs. In this 
sense, toxicity and efficacy in vivo studies are now in progress, also, the chemical study of ethyl 
acetate fraction are currently on-going. 
3. Experimental Section 
3.1. General experimental procedures 
Optical rotations were measured on a Perkin-Elmer model 383 digital polarimeter. NMR spectra 
were recorded in CD3SOCD3, on a Bruker Avance 400 spectrometer. The chemical shifts are given in  
δ (ppm) with residual CD3SOCD3 as internal reference and coupling constants in Hz. FABMS were 
recorded with a NBA matrix in the positive and negative modes, on a JEOL JMS-SX 102A. Precoated 
TLC silica gel 60 F254 aluminum sheets from Merck were used for analytical thin-layer 
chromatography (0.25 mm layer thickness) and the compounds were visualized as purplish spots on 
spraying with 5% methanolic sulfuric acid followed by heating at 100
 °C. Solvent system for TLC was Mar. Drugs 2010, 8                           
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dichloromethane-methanol (85:15). Column chromatography was conducting using Sephadex LH20 
from Sigma-Aldrich. 
3.2. Algal material 
The brown algae Lobophora variegata (J.V. Lamouroux) Womersley ex E.C. Oliveira (Phaeophyta) 
was collected in March 2007 in Puerto Morelos (20°46’N–88°05’W). Once harvested, the alga was 
stored in plastic bags and chilled on ice during transport to the laboratory. A voucher specimen was 
identified according to Littler and Littler [37] and deposited at the Cinvestav Marine Algae Herbarium. 
3.3. Extraction and isolation of 1–3 
Collected samples of Lobophora variegata were washed thoroughly with freshwater to remove 
salts, sand and epiphytes, and stored at −20 °C. Entire plants were lyophilized and milled into powder 
(800 g) and were thoroughly extracted with dichloromethane-methanol (7:3) at room temperature. The 
solvent was removed by distillation at 45 °C to give 35.5 g of crude extract residue. The crude residue 
was dissolved in methanol-water (9:1) and successively subjected to solvent partitioning according to 
Kupchan´s modified method [15] using, hexane, chloroform, ethyl acetate and n-butanol. Five fractions 
of different polarity, including the aqueous one, were obtained. The solvent was eliminated by distillation 
in vacuo, yielding 10.0, 3.6, 16.7, 3.4 and 1.8 g of residue, respectively. The chloroform fraction was 
subjected to column chromatography on Sephadex LH20, eluted with hexane-chloroform-methanol 
3:2:1. A total of 25 fractions (25 mL/each fraction) were collected. Fraction 24 was concentrated, 
precipitated with acetone and filtered to give a mixture of 1–3 (276.3 mg). 
3.4. Alkaline hydrolysis 
A solution of 1–3 (6 mg) in MeOH (0.5 mL) was treated with NaOMe 0.5M in MeOH (1 mL) and 
stirred at room temperature for 5 h. After this time, the reaction mixture was neutralized with Dowex 
50W × 4 and the resin removed by filtration. The filtrate was extracted with hexane and the hexane 
layer was concentrated and analyzed by GC-MS: Agilent Technologies 6890N GC equipped with a 
mass-selective detector 5973Network MSD, a split injector and a silica-capillary GC column HP-5MS 
(30 m × 0.25 mm; i.d. 0.25 μm film, Agilent Technologies, Inc.); the column oven temperature was 
kept at 80 °C for 1 min and then increased at a rate of 15 °C/min up to 310 °C, carrier He, flow rate  
0.8 mL/min. Methyl palmitate, methyl myristate and methyl oleate were detected with retention times 
of 9.64, 11.05 and 12.16 min, respectively. Their retention times and fragmentation peaks were in 
good agreement with those of standard fatty methyl esters. 
3.5. Enzymatic hydrolysis 
The mixture of 1–3 (0.3 mg) was mixed with lipase (1 mg) from Mucor javanicus (Sigma-Aldrich, 
Switzerland, Ec 2326199) in dioxane-H2O (1:1, 1 mL) and the reaction mixture was incubated at 38 °C 
for 4 h. After removal of the dioxane and H2O, the residue was dissolved in 2 mL MeOH and 
partitioned with hexane. The hexane extract was analyzed by GC-MS. Palmitic acid was detected with 
retention time of 11.11 min. Retention time was identical to those of the authentic standard. Mar. Drugs 2010, 8                           
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3.6. Antiprotozoal activity 
Trichomonas vaginalis and Entamoeba histolytica strain GT3 and HM1: IMSS respectively were 
maintained in TYI-S- 33 medium supplemented with10% bovine serum. Giardia intestinalis strain 
IMSS:0696:1 were grown in TYI-S-33 modified medium, supplemented with 10% calf Serum. For the 
assays trophozoites were axenically maintained and employed in the log phase of growth. 
In vitro susceptibility assays used the sub-culture method of Cedillo-Rivera et al. [38]. The extracts 
were dissolved in 1 mL of dimethylsulfoxide (DMSO) and added to microtubes containing 1.5 mL of 
medium in order to reach concentrations of 1.6, 3.3, 6.6, and 13.3 µg/mL. The solutions were 
inoculated with trophozoites to achieve an inoculum 1 × 10
4, 2 × 10
4 and 6 × 10
3 trophozoites/mL of  
T. vaginalis, G. lamblia and E. histolytica, respectively and then incubated for 48 h at 37 °C. Each test 
included metronidazole as standard drug, a control (culture medium plus trophozoites and DMSO), 
and a blank (culture medium). After incubation, the trophozoites were detached by chilling and 
samples of each tube were sub-cultured in fresh medium for another 48 h, without antiprotozoal drugs 
or extracts. The final number of parasites was determined with a haemocytometer and the 50% 
inhibitory concentration (IC50) was calculated by Probit analysis. The concentrations were performed 
twice in each experiment and the experiments were performed by triplicate 
3.7. Cytotoxicity assay 
Madin-Darby canine kidney cell (MDCK) were grown in DMEM (Gibco) media supplemented 
with 10% (v/v) fetal bovine serum (FBS;Gibco) with 100 U/mL penicillin and 100 µg/mL 
streptomycin and maintained at 37 °C in a 5% CO2 atmosphere with 95% humidity. 
Cytotoxicity assays with the crude extract, each one of the fractions (A-E) and the mixture of 1–3, 
were performed according to Rahman et al. [39]. Briefly, 1.5 × 10
4 MDCK viable cells were seeded in 
a 96-well plate (Costar) and incubated for 24–48 h. When reached >80% confluence, the medium was 
replaced and the cells were treated with the crude extracts at 6.25, 12.5, 25 and 50 μg/mL dissolved in 
dimethylsulfoxide (DMSO) at a maximum concentration of 0.05%. After 72 h of incubation, the cells 
were treated as described in Moo-Puc et al., [12]. Metronidazole was used as positive control, whereas 
untreated cells were used as negative controls. The concentration of the substances that killed 50% of 
the cells (CC50%) was calculated by GraphPad Prim 4 software. The concentrations were performed 
twice in each experiment and the experiments were performed by triplicate. 
The selective index (SI) was defined as the ratio of cytotoxicity to biological activity (SI = CC50 
MDCK cells/IC50 protozoa) was calculated. 
4. Conclusions 
The tropical brown alga Lobophora variegata collected from the coast of the Yucatán peninsula, 
México, is a source of antiprotozoal compounds. The whole extract and non-polar fractions from this 
species could be used for development of new antiprotozoal drugs. A mixture of 
sulfoquinovosyldiacylglicerols, SQDGs 1–3 was isolated from the chloroform soluble fraction of 
whole extract of the alga and it comprises a major SQDG, identified as 1-O-palmitoyl-2-O-myristoyl-
3-O-(6´´´-sulfo-α-D-quinovopyranosyl)-glycerol (1), together with small amounts of 1,2-di-O-Mar. Drugs 2010, 8                           
 
 
1302
palmitoyl-3-O-(6´´´-sulfo-α-D-quinovopyranosyl)-glycerol (2) and a new compound identified as   
1-O-palmitoyl-2-O-oleoyl-3-O-(6´´´-sulfo-α-D-quinovopyranosyl)-glycerol (3). This is the first report 
on the presence of the SQDGs 1–3, in Lobophora variegata species. Moreover, the activity against  
G. lamblia and E. histolytica of whole extract and fractions of L. variegata was also revealed for the 
first time in this study. 
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